Benzinga's Top Initiations

By: via Benzinga
Analysts at Guggenheim Securities initiated coverage on Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) with a Buy rating. The target ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.